Staphylococcus aureus peptidoglycan ameliorates cyclophosphamide-induced impairment of wound healing

Wound Repair and Regeneration

Volumn 5, Issue 4, 1997, Pages 364-372

  Imegwu, Obi ^a   Chang, Tsueng H ^a   Steinberg, Jacob J ^a   Levenson, Stanley M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000698685     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1997.50411.x     Document Type: Article

References (45)

1. Des Prez JD, Kiehn CL. The effect of cytoxan (cyclophosphamide) on wound healing. Plast Reconstr Surg 1960;26:301-8.
2. Karpinnen V, Myllarniemi H. Vascular reactions in the healing laparotomy wound under cytostatic treatment. Acta Chir Scand 1970;136:675-80.
3. Mann M, Bednar B, Feit J. Effect of cyclophosphamide on the course of cutaneous wound healing. Neoplasma 1977;24:487-95.
4. Wie H, Brauset I, Eckersberg T. Effects of cyclophosphamide on open granulating skin wounds in rats. Acta Path Microbiol Scand (sect A) 1979;87:185-92.
5. Wie H, Ergesaeter LB, Beck EI. Effects of cyclophosphamide on mechanical properties of bone and skin in rats. Acta Orthop Scand 1979;50:629-34.
6. Shamberger RC, Devereux DF, Brennan MF. Wound healing and the effect of chemotherapeutic agents on wound healing. Inter Adv Surg Oncol 1981;4:15-58.
7. Levenson SM, Kan-Gruber D, Gruber C, Molnar J, Seifter E. Wound healing accelerated by Staphylococcus aureus. Arch Surg 1983;118:310-20.
8. Levenson SM, Chang TH, Kan-Gruber D, Gruber C, Steinberg JJ, Liu X, Watford A, Freundlich L, Rojking M. Accelerating effects of non-viable Staphylococcus aureus, its cell wall, and cell wall peptidoglycan. Wound Rep Reg 1996;4:461-9.
9. Liu X, Levenson SM, Chang TH, Steinberg JJ, Imegwu O, Rojkind M. Molecular mechanisms underlying wound healing acceleration by Staphylococcus aureus peptidoglycan. Wound Rep Reg 1996;4:470-6.
10. Chang TH, Watford A, Freundlich L, Patel M, Steinberg JJ, Levenson SM. Instillation of non-viable Staphylococcus aureus or its peptidoglycan ameliorates glucocoticoid-induced impaired healing. Wound Rep Reg 1997;5:184-90.
11. Levenson SM, Crowley LV, Geever EF, Rosen H, Berard CW. Some studies on wound healing: experimental methods, effect of ascorbic acid and effect of deuterium oxide. J Trauma 1964;4:543-66.
12. Levenson SM, Geever EF, Crowley LV, Oates JF, Berard CW, Rosen H. The healing of rat skin wounds. Arch Surg 1965;161:293-308.
13. Park JJ, Hancock R. A fractionation procedure for studies of the synthesis of cell-wall mucopeptide and of other polymers in cells of Staphylococcus aureus. J Gen Microbiol 1960;22:249-58.
14. Woessner JF. Determination of hydroxyproline in connective tissues. In: Hall DA, editor. The methodology of connective tissue research. Oxford: Jaynson-Bruvvers Ltd; 1976.p.227-33.
15. Moore MJ. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacol 1991;20:194-208.
16. Kotani S, Watanabe Y, Shimono T, Narita T, Kato K. Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits prepared from various Gram- positive bacteria and of synthetic N-acetylmuramyl peptides. Z Immunitatsforsch Exp Klin Immunol 1975;149:302-19.
17. Pimenov AA, Rakhmilevich AL, Deev VV, Kirillova IV, Migdal TL, Andronova TM, Fuks BB. Activation of cellular immunity in mice under normal conditions and in tumor growth during treatment with glucosamyl muramyl dipeptide in vitro. Antibiot-Khimoter 1989;34:836-9.
18. Stratford F, Seifter E, Rettura G, Babyatsky M, Levenson SM. Impaired wound healing due to cyclophosphamide alleviated by supplemental vitamin A. Surg Forum 1980;XXXI:224-5.
19. Moon RC, Grubbs CJ, Sporn MB, Goodman DG. Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosourea. Nature 1977;267:620-1.
20. Seidl PH, Schleifer KH, editors. Biological properties of peptidoglycan. Berlin: DeGruyter and Co; 1986.
21. Schleifer KH. Chemical structure of peptidoglycan, its modifiability, and relation to biological activity. Immuno-Forsch Bd 1975;149:S104-17.
22. Dziarski R. Effects of peptidoglycan on the cellular components of the immune system. In: Seidl PH, Schleifer KH, editors. Biological properties of peptidoglycan. Berlin: DeGruyter and Co; 1986.p.229-47.
23. Riber U, Espersen F, Wilkinson BJ, Kharazmi A. Neutrophil chemotactic activity of peptidoglycan: a comparison between Staphylococcus aureus and Staphylococcus epidermidis. APMIS 1990;98:881-6.
24. Jupin C, Parant M, Chedid L, Damais C. Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides. Inflammation 1987;11:153-61.
25. Dziarski R. Correlation between ribosylation of pertussis toxin substrates and inhibition of peptidoglycan muramyl dipeptide and lipopolysaccharide-induced mitogenic stimulation in B lymphocytes. Eur J Immunol 1989;19:125-30.
26. Keller R, Gehri R, Keist R, Huf E, Kayser FH. The interaction of macrophages and bacteria: a comparative study of the induction of tumoricidal activity and of reactive nitrogen intermediates. Cell Immunol 1991;134:249-56.
27. Lafyatis R, Thompson NL, Remmers EF, Flanders KC, Roche NS, Kim SJ, Case JP, Sporn MB, Roberts AB, Wilder RL. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats: studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol 1989;143:1142-8.
28. Vacheron F, Guenounou M, Zinbi H, Nauciol C. Release of a cytotoxic factor by macrophage stimulated with adjuvant active peptidoglycans. J Natl Cancer Inst 1986;77:549-53.
29. Ryc M, Rotta J, Straka R, Zaoral M, Jezek J, Farkas J, Krchnak V. Blood-platelets-damaging activity of some synthetic Streptococcus peptidoglycan subunits and analogues. Zentralbl Bakeriol Mikrobiol Hyg (A) 1987;263:577-84.
30. Ray PK, Dohadwala M, Bandyophachyay SK, Canchanapan P, McLaughlin D. Rescue of rats from large dose cyclophosphamide toxicity using protein A. Cancer Chemother Pharmacol 1985;14:59-62.
31. Dohadwala M, Ray PK. In vivo protection by protein A of hepatic microsomal mixed function oxygenase system of cyclophosphamide treated rats. Cancer Chemother Pharmacol 1985;14:135-8.
32. Cohen SC, Gabelnick HL, Johnson RK, Goldin A. Effects of Cyclophosphamide and adriamycin on the healing of surgical wounds in mice. Cancer 1975;36:1277-81.
33. Haschek WM, Klein-Szanto AJP, Last JA, Reiser KM, Witschi HP. Long-term morphologic and biochemical features of experimentally induced lung fibrosis in the mouse. Lab Invest 1982;46:438-9.
34. Gould VE, Miller J. Sclerosing alveolitis induced by cyclophosphamide: ultrastructural observation of alveolar injury and repair. Am J Pathol 1975;81:513-30.
35. Adamson IY. Drug-induced pulmonary fibrosis. Environ Health Perspect 1984;55:25-36.
36. Morse CC, Sigler C, Lock S, Hakkinen PJ, Haschek WM, Witschi HP. Pulmonary toxicity of cyclophosphamide: a 1-year study. Exp Mol Pathol 1985;42:251-60.
37. Hoyt DG, Lazo JS. Early increases in pulmonary mRNA encoding procollagens and transforming growth factor-β in mice sensitive to cyclophosphamide induced pulmonary fibrosis. J Pharmacol Exp Thera 1989;249:38-43.
38. Mastrangelo MJ, Berd D, Maguire H Jr. The immunoaugmenting effects of cancer chemotherapeutic agents. Sem Oncol 1986;13:186-94.
39. Kerckhaert JA, Hofhuis FM, Willers JM. Effects of variations in time and dose of cyclophosphamide injection on delayed hypersensitivity and antibody formation. Cell Immunol 1977;29:232-7.
40. Askenase PW, Hayden BJ, Gershon RK. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med 1975;141:697-702.
41. Kaufmann SHE, Hahn H, Diamantstein T. Relative susceptibility of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphatide. J Immunol 1980;125:1104-8.
42. Gill HK, Liew FY. Regulation of delayed-type hypersensitivity; III: effect of cyclophosphamide on the suppressor cells for delayed type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol 1978;8:172-6.
43. L'Age-Stehr J, Diamanstein T. Induction of autoreactive T-lymphocytes and their suppressor cells by cyclophosphamide. Nature 1978;271:663-5.
44. Mitsuoka A, Baba M, Morikawa S. Enhancement of delayed hypersensitively by depletion of suppressor T-cells with cyclophosphamide in mice. Nature 1976;262:77-8.
45. Barbul A, Breslin RJ, Woodyard JP, Wasserkrug HL, Efron G. The effect of in vivo T helper and T suppressor lymphocyte depletion on wound healing. Ann Surg 1989;209:479-83.